Bot Detector
Download FREE Sample Issue or Article
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Postherpetic Neuralgia

Author(s):  Angelle Patsy

Issue:  Jan/Feb 2000 - Compounding for Pain Management
View All Articles in Issue

Page(s):  27-29

Postherpetic Neuralgia Page 1
Postherpetic Neuralgia Page 2
Postherpetic Neuralgia Page 3

Download in electronic PDF format for $75

Abstract:  Postherpetic neuralgia is the result of damage to the nervous system by an acute herpes zoster infection. The author presents three case reports illustrating the benefits of a multifaceted treatment approach. She concludes that postherpetic neuralgia results in a continuous and prolonged excitation at the pain receptor sites. The success of adjunctive topical treatment using multiple agents that possess varied modes of action substantiates the possibility of improving therapeutic modalities in this patient population. The collaborative efforts of the health-care team are extremely important.

Related Keywords: 2-deoxy-D-glucose, acetylsalicylic acid, acetylsalicylic acid/chloroform solution, amitriptyline, blisters, chicken-pox, clonidine, dermatome, dexamethasone, famciclovir, gabapentin, herpes zoster, ketamine, ketoprofen, lidocaine, PLO, postherpetic neuralgia, postherpetic pain, shingles, varicella-zoster virus, vesicular lessions

Related Categories: PAIN MANAGEMENT

Printer-Friendly Version

Related Articles from IJPC
(Click for Abstract / Details / Purchase)
Postherpetic Neuralgia
Angelle Patsy
Jan/Feb 2000
Pg. 27-29

Acidifying Agents, Featured Excipient:
Allen Loyd V Jr
Jul/Aug 1999
Pg. 309-310

Trichloroacetic Acid 20%, Salicylic Acid 20%, Lactic Acid 10% in Flexible Collodion
Allen Loyd V Jr
Sep/Oct 2015
Pg. 410

Case Report: Shingles Triple Cream in the Treatment of Herpes Zoster
Fields Shannon W
Mar/Apr 2007
Pg. 131

Veterinary 2-deoxy-D-glucose Ophthalmic Ointment
Allen Loyd V Jr
May/Jun 1998
Pg. 206-207

Ketamine Hydrochloride 5%, Gabapentin 10%, Clonidine Hydrochloride 0.2%, and Baclofen 2% in Lipoderm
Allen Loyd V Jr
May/Jun 2016
Pg. 231

Ketamine Hydrochloride 5%, Gabapentin 10%, Clonidine Hydrochloride 0.2%, and Baclofen 2% in Lipoderm
Allen Loyd V Jr
Mar/Apr 2024
Pg. 135

Ketamine HCl 10%, Gabapentin 6%, Baclofen 2%, Amitriptyline HCl 2% and Clonidine HCl 0.1% in PLO
Allen Loyd V Jr
Mar/Apr 2000
Pg. 133

Basics of Compounding for Disorders of the External Ear
Allen Loyd V Jr
Jan/Feb 2004
Pg. 46-48

Basics of Compounding for the Treatment of Warts
Allen Loyd V Jr
Mar/Apr 2004
Pg. 126-129

Miconazole Nitrate 2%, Deoxy-D-Glucose 0.2%, and Hydrocortisone 0.4% Lip Balm
Allen Loyd V Jr
May/Jun 2008
Pg. 265

Basics of Compounding for Cold Sores or Fever Blisters
Allen Loyd V Jr
May/Jun 2004
Pg. 206-209

Sodium Acetate-Boric Acid-Acid Stock Solution for Ophthalmic Preparations
Allen Loyd V Jr
May/Jun 1998
Pg. 190

Stability of Aminocaproic Acid Injection Admixtures in 5% Dextrose Injection and 0.9% Sodium Chloride Injection
Zhang Yan-ping
, Trissel Lawrence A
Mar/Apr 1997
Pg. 132-134

Physicochemical Stability of Compounded Creams Containing alpha-Hydroxy Acids
de Villiers Melgardt M
, Narsai Kirti, van der Watt Jakkie G
Jan/Feb 2000
Pg. 72-75

Compounding Pharmacies' Potential to Create Graft Storage Solutions for Bypass Surgeries
Guth Michael AS
Sep/Oct 2015
Pg. 367-373

Gabapentin 100-mg/mL Oral Liquid
Allen Loyd V Jr
Nov/Dec 2006
Pg. 456

Clonidine HCl 0.2%, Gabapentin 6%, and Ketamine HCl 10% in a Pluronic Lecithin Organogel (PLO)
Allen Loyd V Jr
Jan/Feb 2002
Pg. 42

Clonidine HCl 0.2%/Gabapentin 6%/Ketamine HCl 10% in Pluronic Lecithin Organogel (PLO)
Hinkle Amanda R
, Newton Gail D
May/Jun 2004
Pg. 185

Chemical Facial Peel Formulations: an Overview
Levine Phillip J
Sep/Oct 1999
Pg. 375-377

Return to Top